Anzeige
Mehr »
Login
Sonntag, 12.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
173 Leser
Artikel bewerten:
(0)

Housing Association Funding Plc - Notice to Noteholders

Finanznachrichten News

Housing Association Funding Plc - Notice to Noteholders

PR Newswire

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTIONOF NOTEHOLDERS. IF NOTEHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD SEEK THEIR OWN FINANCIAL, LEGAL OR OTHER PROFESSIONAL ADVICE, INCLUDING AS TO ANY TAX CONSEQUENCES, IMMEDIATELY FROM THEIR STOCKBROKER, SOLICITOR, ACCOUNTANT OR OTHER INDEPENDENT FINANCIAL, LEGAL OR OTHER PROFESSIONAL ADVISER

If you have recently sold or otherwise transferred your entire holding(s) of the Notes referred to below, you should immediately forward this document to the purchaser or transferee or to the broker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

NOTICE TO NOTEHOLDERS

To the holders of the £192,270,000 8.25 per cent. Secured Loan-Backed Notes due June 2027 ISIN: XS0073407537

(the "Notes")

issued by Housing Association Funding PLC

(the "Issuer")

Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (Market Abuse Regulation) requires disclosure by or on behalf of the Issuer of any inside information concerning the Issuer.

Capitalised terms used but not otherwise defined herein shall have the meanings ascribed to them in the master schedule of definitions, interpretation and construction clauses dated 23 January 1997, as amended and restated on 30 January 1998, as amended and restated on 23 December 1999, as amended and restated on 29 June 2005, as amended and restated on 7 December 2009, as amended and restated on 11 February 2010 and as further amended and restated on 31 January 2017.

We refer to the notice of the Issuer dated 4 November 2021 in which the Issuer informed Noteholders that A2 Dominion South Limited (formerly known as Airways Housing Society Limited) ("A2 Dominion South Limited") provided notice of prepayment of their loan, together with interest accrued up to the date of prepayment and the relevant Prepayment Premium on the next Combined Payment Date (as defined in its Loan Agreement and the Consent Solicitation Memorandum) on 6 December 2021.

Pursuant to the terms of the Loan Agreement the Issuer notified the Borrower and the Trustee of the price determined by the Issuer's financial adviser under Condition 5(g) for the corresponding redemption of the Notes over par (if any).

The Issuer has received the following amounts in relation to the prepayment:

A2 Dominion South Limited

  • £3,138,526.59 being the total principal outstanding under its loans.
  • £343,375.55 comprising the relevant Combined Payment.
  • £557,279.00 comprising the relevant Prepayment Premium.
  • £46,544.32 of outstanding fees, costs and expenses payable by A2 Dominion South Limited.

Pursuant to the Supplemental Trust Deed, the amount of the prepayment is required to be applied to redeem the Notes on the Interest Payment Date (as defined in the Trust Deed) falling on 7 December 2021 in accordance with the terms of the Transaction Documents.

Queries may be addressed to the Issuer as follows:

Housing Association Funding PLC:

Address: Bastion House, 6th Floor, 140 London Wall, London, England, EC2Y 5DN

Attention: The Directors

Telephone: +44 203 994 7157

Email: spvservices@apexfs.com

HOUSING ASSOCIATION FUNDING PLC

6 December2021

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.